Budesonide Sales Data
| Rank 56 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows budesonide U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 56 ( 22) |
$268,201 | 26.81% | 12,849 | 60.65% |
| Q3 2013 | 78 ( 17) |
$211,501 | -13.96% | 7,998 | -21.09% |
| Q2 2013 | 61 (11) |
$245,828 | -9.50% | 10,135 | -18.72% |
| Q1 2013 | 50 (2) |
$271,635 | 2.21% | 12,470 | 0.81% |
| Q4 2012 | 52 (37) |
$265,773 | 42.52% | 12,370 | 60.17% |
| Q3 2012 | 89 (8) |
$186,479 | -3.36% | 7,723 | -17.22% |
| Q2 2012 | 81 (18) |
$192,961 | -24.99% | 9,330 | -28.55% |
| Q1 2012 | 63 (6) |
$257,243 | -3.57% | 13,058 | -2.53% |
| Q4 2011 | 57 (28) |
$266,769 | 51.97% | 13,397 | 48.34% |
| Q3 2011 | 85 (10) |
$175,543 | 5.36% | 9,031 | 25.08% |
| Q2 2011 | 95 (18) |
$166,615 | -24.47% | 7,220 | -29.37% |
| Q1 2011 | 77 | $220,600 | n/a | 10,223 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
